Investigational Drugs List
Groups Distribution
Phase Distribution
Filter Conditions
Investigational Drugs List
| Drugs ID | CID | Drugs | Identifier | Molecular Formula | Molecular Weight | Groups | US Approved | Details |
|---|---|---|---|---|---|---|---|---|
| Drug151 | 71600085 | Uproleselan | NULL | C60H109N3O27 | 1304.50 | NULL | NULL | Details |
| Drug152 | 71616860 | GLPG1205 | NCT02337608 | C22H22N2O4 | 378.40 | NULL | NULL | Details |
| Drug153 | 71622431 | Ivarmacitinib | NCT05181137, NCT03675477 | C18H22N8O2S | 414.50 | NULL | NO | Details |
| Drug154 | 77108121 | GSK2982772 | NCT02903966 | C20H19N5O3 | 377.40 | NULL | NULL | Details |
| Drug155 | 81689783 | TOP1288 | NCT02888379, NCT02463045, NCT03071081 | C43H49N7O9S | 840.00 | NULL | NULL | Details |
| Drug156 | 88944400 | PL8177 | NCT05466890 | C48H65N15O9 | 996.10 | NULL | NULL | Details |
| Drug157 | 91663255 | Iron Sucrose | NCT00810030, NCT01067547 | C12H29Fe5Na2O23 | 866.50 | NULL | YES | Details |
| Drug158 | 117877477 | SPH3127 | NCT05019742, NCT05770609 | C22H32N6O4 | 444.50 | NULL | NULL | Details |
| Drug159 | 118115473 | Ritlecitinib | NCT02958865 | C15H19N5O | 285.34 | NULL | YES | Details |
| Drug160 | 118166560 | LYS006 | NCT04074590 | C16H14ClFN6O3 | 392.77 | NULL | NULL | Details |